Loading…
buy-pharma.md sold unapproved and misbranded drug products through its website that claimed to mitigate, prevent, treat, diagnose, or cure COVID-19 and other diseases including lupus, rheumatoid arthritis, and malaria, violating sections 505(a) and 502 of the Federal Food, Drug, and Cosmetic Act. The company introduced these products into interstate commerce without FDA approval or authorization during the declared public health emergency and national emergency related to COVID-19, exposing U.S. consumers to the inherent risks of unapproved and misbranded drugs sold over the internet.